216 related articles for article (PubMed ID: 24498386)
61. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
[TBL] [Abstract][Full Text] [Related]
62. Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights.
Mas L; Lupinacci RM; Cros J; Bachet JB; Coulet F; Svrcek M
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201897
[TBL] [Abstract][Full Text] [Related]
63. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
[TBL] [Abstract][Full Text] [Related]
64. GNAS and KRAS mutational analyses of intraductal papillary neoplasms of the pancreas and bile duct developing in the same individual: A case report.
Date K; Ohtsuka T; Fujimoto T; Gotoh Y; Nakashima Y; Kimura H; Matsunaga T; Mori Y; Mochidome N; Miyazaki T; Oda Y; Tanaka M; Nakamura M
Pancreatology; 2015; 15(6):713-6. PubMed ID: 26506885
[TBL] [Abstract][Full Text] [Related]
65. Liver-intestine cadherin expression is associated with intestinal differentiation and carcinogenesis in intraductal papillary mucinous neoplasm.
Morimatsu K; Aishima S; Kayashima T; Hayashi A; Nakata K; Oda Y; Taguchi T; Tsuneyoshi M; Tanaka M; Oda Y
Pathobiology; 2012; 79(2):107-14. PubMed ID: 22286087
[TBL] [Abstract][Full Text] [Related]
66. Serine/Threonine Kinase 11 Plays a Canonical Role in Malignant Progression of KRAS -Mutant and GNAS -Wild-Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Omori Y; Ono Y; Morikawa T; Motoi F; Higuchi R; Yamamoto M; Hayakawa Y; Karasaki H; Mizukami Y; Unno M; Furukawa T
Ann Surg; 2023 Feb; 277(2):e384-e395. PubMed ID: 33914475
[TBL] [Abstract][Full Text] [Related]
67. Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.
Nissim S; Idos GE; Wu B
Pancreas; 2012 Nov; 41(8):1195-205. PubMed ID: 22750975
[TBL] [Abstract][Full Text] [Related]
68. [Pancreatic tumor: progress in diagnosis and treatment. Topics: II. Intraductal papillary mucinous neoplasm of the pancreas (IPMN)/mucinous cystic neoplasm (MCN); 2. Pathology and pathobiology].
Furukawa T; Kuboki Y; Hatori T; Yamamoto M; Shibata N; Shiratori K
Nihon Naika Gakkai Zasshi; 2012 Jan; 101(1):57-63. PubMed ID: 22413462
[No Abstract] [Full Text] [Related]
69. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
[TBL] [Abstract][Full Text] [Related]
70. [Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].
Ji Y; Tan YS; Zhu XZ; Zeng HY; Kuang TT; Jin DY
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):77-81. PubMed ID: 16630480
[TBL] [Abstract][Full Text] [Related]
71. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.
Flanagan MR; Jayaraj A; Xiong W; Yeh MM; Raskind WH; Pillarisetty VG
World J Gastroenterol; 2015 Mar; 21(9):2820-5. PubMed ID: 25759555
[TBL] [Abstract][Full Text] [Related]
72. Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas.
Ikemoto T; Sugimoto K; Shimada M; Utsunomiya T; Morine Y; Imura S; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Yamada S
J Gastroenterol Hepatol; 2015 Jan; 30(1):217-22. PubMed ID: 25041344
[TBL] [Abstract][Full Text] [Related]
73. Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after resection of an intraductal papillary-mucinous carcinoma of the pancreatic head: a case report and comparison of DNA sequence in K-ras gene mutation.
Komori T; Ishikawa O; Ohigashi H; Yamada T; Sasaki Y; Imaoka S; Nakaizumi A; Uehara H; Tanaka S; Mano Y; Kasugai T
Jpn J Clin Oncol; 2002 Apr; 32(4):146-51. PubMed ID: 12072425
[TBL] [Abstract][Full Text] [Related]
74. Aberrant expression of cdx2 homeobox gene in intraductal papillary-mucinous neoplasm of the pancreas but not in pancreatic ductal adenocarcinoma.
Yeh TS; Ho YP; Chiu CT; Chen TC; Jan YY; Chen MF
Pancreas; 2005 Apr; 30(3):233-8. PubMed ID: 15782100
[TBL] [Abstract][Full Text] [Related]
75. Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with the biological behavior of the tumor.
Yonezawa S; Horinouchi M; Osako M; Kubo M; Takao S; Arimura Y; Nagata K; Tanaka S; Sakoda K; Aikou T; Sato E
Pathol Int; 1999 Jan; 49(1):45-54. PubMed ID: 10227724
[TBL] [Abstract][Full Text] [Related]
76. Activating mutations of GNAS and KRAS in cystic fluid can help detect intraductal papillary mucinous neoplasms of the pancreas.
Frampton AE; Stebbing J; Gall TM; Silver B; Jiao LR; Krell J
Expert Rev Mol Diagn; 2015 Mar; 15(3):325-8. PubMed ID: 25656048
[TBL] [Abstract][Full Text] [Related]
77. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW
J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570
[TBL] [Abstract][Full Text] [Related]
78. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M
Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
[TBL] [Abstract][Full Text] [Related]
79. Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas.
Dal Molin M; Hong SM; Hebbar S; Sharma R; Scrimieri F; de Wilde RF; Mayo SC; Goggins M; Wolfgang CL; Schulick RD; Lin MT; Eshleman JR; Hruban RH; Maitra A; Matthaei H
Hum Pathol; 2012 Apr; 43(4):585-91. PubMed ID: 21940037
[TBL] [Abstract][Full Text] [Related]
80. The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review.
Lin YL; Ma R; Li Y
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2179-2188. PubMed ID: 32700107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
